SCHEMBL29705174

SCHEMBL29705174

CCOC(=O)c1cn(C)c2ncc(B(O)O)cc2c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BAZ2B Q9UIF8 1/20 0.44
BAZ2A Q9UIF9 1/20 0.44
LMNA P02545 2/20 0.41
KDM4E B2RXH2 6/20 0.40
GAA P10253 4/20 0.40
GLA P06280 3/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HPGD P15428 2/20 0.37
DPP4 P27487 1/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20521025 1.00 BAZ2B (0.44) BAZ2BBAZ2ALMNAKDM4EGAA
SCHEMBL29705211 0.87 LMNA (0.50) LMNAKDM4ENPC1RAB9AKMT2A
SCHEMBL20521839 0.87 LMNA (0.50) LMNAKDM4ENPC1RAB9AKMT2A
SCHEMBL20556271 0.86 CYP1A2 (0.42) LMNAKDM4EGAANPC1RAB9A
SCHEMBL29705130 0.86 CYP1A2 (0.42) LMNAKDM4EGAANPC1RAB9A
SCHEMBL20521059 0.85 KDM4E (0.40) LMNAKDM4EGAAGLANPC1
SCHEMBL29705131 0.85 KDM4E (0.40) LMNAKDM4EGAAGLANPC1
SCHEMBL20520935 0.85 LMNA (0.41) LMNAKDM4EGLANPC1RAB9A
SCHEMBL22010180 0.84 ADRB2 (0.43) LMNAKDM4EGAAGLANPC1
SCHEMBL21815626 0.83 LMNA (0.53) BAZ2BBAZ2ALMNAKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110475777-B Novel pyrido [2,3-b ] indole compounds for the treatment and prevention of bacterial infections 豪夫迈·罗氏有限公司 2022-04-15 CN disclosed